Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica

Abstract Doxorubicin (DOX), a common chemotherapeutic agent, impairs synaptic plasticity. DOX also causes a persistent increase in basal neuronal excitability, which occludes serotonin-induced enhanced excitability. Therefore, we sought to characterize and reverse DOX-induced physiological changes a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Harini Lakshminarasimhan, Brittany L. Coughlin, Amber S. Darr, John H. Byrne
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9085c26eb1104bab9ba19e4f21ed459b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9085c26eb1104bab9ba19e4f21ed459b
record_format dspace
spelling oai:doaj.org-article:9085c26eb1104bab9ba19e4f21ed459b2021-12-02T16:06:30ZCharacterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica10.1038/s41598-017-04634-42045-2322https://doaj.org/article/9085c26eb1104bab9ba19e4f21ed459b2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04634-4https://doaj.org/toc/2045-2322Abstract Doxorubicin (DOX), a common chemotherapeutic agent, impairs synaptic plasticity. DOX also causes a persistent increase in basal neuronal excitability, which occludes serotonin-induced enhanced excitability. Therefore, we sought to characterize and reverse DOX-induced physiological changes and modulation of molecules implicated in memory induction using sensory neurons from the marine mollusk Aplysia californica. DOX produced two mechanistically distinct phases of extracellular signal-regulated kinase (ERK) activation, an early and a late phase. Inhibition of MEK (mitogen-activated protein kinase (MAPK)/ERK kinase) after DOX treatment reversed the late ERK activation. MEK inhibition during treatment enhanced the late ERK activation possibly through prolonged downregulation of MAPK phosphatase-1 (MKP-1). Unexpectedly, the late ERK activation negatively correlated with excitability. MEK inhibition during DOX treatment simultaneously enhanced the late activation of ERK and blocked the increase in basal excitability. In summary, we report DOX-mediated biphasic activation of ERK and the reversal of the associated changes in neurons, a potential strategy for reversing the deleterious effects of DOX treatment.Harini LakshminarasimhanBrittany L. CoughlinAmber S. DarrJohn H. ByrneNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Harini Lakshminarasimhan
Brittany L. Coughlin
Amber S. Darr
John H. Byrne
Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica
description Abstract Doxorubicin (DOX), a common chemotherapeutic agent, impairs synaptic plasticity. DOX also causes a persistent increase in basal neuronal excitability, which occludes serotonin-induced enhanced excitability. Therefore, we sought to characterize and reverse DOX-induced physiological changes and modulation of molecules implicated in memory induction using sensory neurons from the marine mollusk Aplysia californica. DOX produced two mechanistically distinct phases of extracellular signal-regulated kinase (ERK) activation, an early and a late phase. Inhibition of MEK (mitogen-activated protein kinase (MAPK)/ERK kinase) after DOX treatment reversed the late ERK activation. MEK inhibition during treatment enhanced the late ERK activation possibly through prolonged downregulation of MAPK phosphatase-1 (MKP-1). Unexpectedly, the late ERK activation negatively correlated with excitability. MEK inhibition during DOX treatment simultaneously enhanced the late activation of ERK and blocked the increase in basal excitability. In summary, we report DOX-mediated biphasic activation of ERK and the reversal of the associated changes in neurons, a potential strategy for reversing the deleterious effects of DOX treatment.
format article
author Harini Lakshminarasimhan
Brittany L. Coughlin
Amber S. Darr
John H. Byrne
author_facet Harini Lakshminarasimhan
Brittany L. Coughlin
Amber S. Darr
John H. Byrne
author_sort Harini Lakshminarasimhan
title Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica
title_short Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica
title_full Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica
title_fullStr Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica
title_full_unstemmed Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica
title_sort characterization and reversal of doxorubicin-mediated biphasic activation of erk and persistent excitability in sensory neurons of aplysia californica
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/9085c26eb1104bab9ba19e4f21ed459b
work_keys_str_mv AT harinilakshminarasimhan characterizationandreversalofdoxorubicinmediatedbiphasicactivationoferkandpersistentexcitabilityinsensoryneuronsofaplysiacalifornica
AT brittanylcoughlin characterizationandreversalofdoxorubicinmediatedbiphasicactivationoferkandpersistentexcitabilityinsensoryneuronsofaplysiacalifornica
AT ambersdarr characterizationandreversalofdoxorubicinmediatedbiphasicactivationoferkandpersistentexcitabilityinsensoryneuronsofaplysiacalifornica
AT johnhbyrne characterizationandreversalofdoxorubicinmediatedbiphasicactivationoferkandpersistentexcitabilityinsensoryneuronsofaplysiacalifornica
_version_ 1718384975246524416